# US 2002/0119505 A1 · Phosphoprotein binding agents and methods of their use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0119505 A1
- Document ID: US20020119505A1
- Status: Published application
- Kind: A1
- Application number: 09/788,286
- Filed: 2001-02-16
- Published: 2002-08-29
- Earliest claimed: 2001-02-16
- Assignees: Battelle Memorial Institute
- Inventors: Michael B. Goshe; Thomas P. Conrads; Timothy D. Veenstra; Ellen A. Panisko
- Web page: https://patentgrep.com/patent/US20020119505A1

## CPC

- G01N 33/6842: {Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins}
- G01N 33/6803: {General methods of protein analysis not limited to specific proteins or families of proteins}
- Y10S 530/811: Peptides or proteins is immobilized on, or in, an inorganic carrier
- Y10T 436/13: Tracers or tags
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The invention provides reagents and methods for characterizing (i.e., identification and/or quantitation) the phosphorylation states of proteins. Proteins may be post-transcriptionally modified such that they contain phosphate groups at either some or all of their serine, threonine, tyrosine, histidine, and/or lysine amino acid residues. In many cases the extent to which a protein is phosphorylated determines it bioactivity, i.e., its ability to effect cell functions such as differentiation, division, and metabolism. Hence, a powerful tool for diagnosing various diseases and for furthering the understanding of protein-protein interactions is provided.

## Claims

### Claim 1

A method of comparing the phosphorylation states of one or more proteins in two or more samples comprising:
providing a substantially chemically identical and differentially isotopically labeled protein reactive reagent for each sample wherein the protein reactive reagent satisfies the formula:
B-L-PhRG
wherein B is a binding agent that selectively binds to a capture reagent (CR), L is a linker group having one or more atoms that are differentially labeled with one or more stable isotopes, and PhRG is a phosphate reactive group that selectively reacts with amino acid residues that were formerly phosphorylated;
reacting each sample with one of the protein reactive reagents to provide proteins bound to the protein reactive reagent, whereby such bound proteins are differentially labeled with stable isotopes;
capturing bound proteins of the samples using the capture reagent that selectively binds the binding agent;
releasing captured bound proteins from the capture reagent by disrupting the interaction between the binding agent and the capture reagent; and
detecting the released bound proteins.

### Claim 2 (depends on 1)

The method of claim 1, wherein the bound proteins in the samples are enzymatically or chemically processed to convert them into bound peptides.

### Claim 3 (depends on 1)

The method of claim 1, wherein a protein portion of one or more of the bound proteins are sequenced by tandem mass spectrometry to identify the bound protein.

### Claim 4 (depends on 1)

The method of claim 1, wherein the amount of one or more phosphorylated proteins in the sample is determined by mass spectrometry and further comprising introducing into a sample a known amount of one or more internal standards for each protein to be quantified.

### Claim 5 (depends on 1)

The method of claim 1, wherein one or more phosphorylated amino acid residues are selected from the group consisting of threonine, serine, and tyrosine.

### Claim 6 (depends on 1)

The method of claim 1, wherein the released bound proteins are separated by chromatography prior to detecting the bound proteins by mass spectrometry.

### Claim 7 (depends on 1)

The method of claim 1, wherein a plurality of proteins in a single sample are detected and identified.

### Claim 8 (depends on 3)

The method of claim 3, wherein all of the proteins in a sample are identified.

### Claim 9 (depends on 1)

The method of claim 1, wherein relative amounts of one or more proteins in two or more samples are determined and further comprising combining differentially labeled samples, capturing bound proteins from the combined samples and measuring relative abundances of the bound proteins differentially labeled proteins.

### Claim 10 (depends on 1)

The method of claim 1, wherein the proteins being quantified are membrane proteins.

### Claim 11 (depends on 1)

The method of claim 1, wherein different samples contain proteins originating from different organelles or different subcellular fractions.

### Claim 12 (depends on 9)

The method of claim 9, wherein different samples represent proteins expressed in response to different environmental or nutritional conditions, different chemical or physical stimuli or at different times.

### Claim 13 (depends on 1)

The method of claim 1, wherein the different samples represent proteins expressed in different disease states.

### Claim 14

A method for screening for a therapeutic that alters a phosphorylation state of a protein, the method comprising:
contacting at least one test sample containing the protein with the therapeutic;
providing at least one control sample containing the protein;
removing one or more phosphate groups from one or more amino acid residues of the protein in the at least one test sample and the at least one control sample;
tagging the at least one test sample and the at least one control sample with substantially chemically identical and differentially isotopically labeled protein reactive reagents for each sample, wherein the protein reactive reagents satisfies the formula:
B-L-PhRG
wherein B is a binding agent that selectively binds to a capture reagent, L is a linker group having one or more atoms that are differentially labeled with one or more stable isotopes, and PhRG is a phosphate reactive group that selectively reacts with amino acid residues that were formerly phosphorylated; and
detecting a level of phosphorylation of the tagged proteins in the at least one test sample and the at least one control sample; and
determining whether the therapeutic altered the level of phosphorylation of the tagged proteins in the at least one test sample.

### Claim 15

A reagent for mass spectrometric analysis of proteins that satisfies the general formula:
B-L-PhRG
where B is a binding agent that selectively binds to a capture reagent, L is a linker group that comprises at least one isotopically heavy atom and a phosphorylation reactive group (PhRG) that selectively labels proteins at one or more residues that were formerly occupied by phosphate groups.

### Claim 16 (depends on 15)

The reagent of claim 15, wherein PhRG is selected from the group consisting essentially of primary amines, secondary amines, tertiary amines, lactams, amides, imides, hydroxylamines, hydrazides, hydrazines, sulfites, sulfinates, sulfonamides, and mixtures thereof.

### Claim 17 (depends on 15)

The reagent of claim 15 wherein the isotopically heavy atom is selected from the group consisting of 2H, 13C, 15N, 17O, 18O, and 34S.

### Claim 18 (depends on 15)

The reagent of claim 15, wherein the reagent is soluble in a liquid protein sample.

### Claim 19 (depends on 15)

The reagent of claim 15, wherein the linker is a cleavable linker.

### Claim 20 (depends on 15)

The reagent of claim 15, wherein the binding agent is biotin or a modified biotin.

### Claim 21 (depends on 15)

The reagent of claim 15, wherein the binding agent is selected from a group consisting essentially of a 1,2-diol, glutathione, maltose, a nitrilotriacetic acid, or an oligohistidine.

### Claim 22 (depends on 15)

The reagent of claim 15, wherein the affinity label is a hapten.

### Claim 23

A reagent for mass spectrometric analysis of proteins that satisfies the general formula:
B-B1-X1-(CH2)n-[X2-(CH2)m]X-X3-(CH2)p-X4-B2-PhRG
where: B is a binding agent, PhRG is a phosphate reactive group, B1−X1-(CH2)n-[X2-(CH2)m]X-X3-(CH2)p-X4-B2 is a linker group, wherein: X1, X2, X3 and X4, are independently selected from a group consisting essentially of O, S, NH, NR, NRR1+, CO, COO, COS, S-S, SO, SO2, CO-NR, CS-NR′, Si-O, aryl or diaryl, wherein at least one of the X1, X2, X3 and X4 groups comprises an isotopically heavy atom.

### Claim 24

A method of detecting more than one type of phosphorylated amino acid residue in a protein, the method comprising:
removing the phosphate group from at least one serine residue or at least one threonine residue;
removing the phosphate group from at least one tyrosine residue;
tagging the at least one serine residue or the at least one threonine residue with substantially chemically identical and differentially isotopically labeled protein reactive reagents for each sample, wherein the protein reactive reagents satisfies the formula:
B-L-PhRG
wherein B is a binding agent that selectively binds to a capture reagent, L is a linker group having one or more atoms that are differentially labeled with one or more stable isotopes, and PhRG is a phosphate reactive group that selectively reacts with amino acid residues that were formerly phosphorylated;
tagging the at least one tyrosine residue with substantially chemically identical and differentially isotopically labeled protein reactive reagents for each sample, wherein the protein reactive reagents satisfies the formula:
B-L-PhRG
wherein B is a binding agent that selectively binds to a capture reagent, L is a linker group having one or more atoms that are differentially labeled with one or more stable isotopes, and PhRG is a phosphate reactive group that selectively reacts with amino acid residues that were formerly phosphorylated; and
detecting the tagged protein.

### Claim 25 (depends on 24)

The method of claim 24, wherein the removing the phosphate group from at least one serine residue or at least one threonine residue is after the removing the phosphate group from at least one tyrosine residue.

### Claim 26 (depends on 24)

The method of claim 24, wherein tagging the at least one serine residue or the at least one threonine residue is done after the tagging the at least one tyrosine residue.

### Claim 27 (depends on 26)

The method of claim 26, wherein the removing the phosphate group from at least one serine residue or at least one threonine residue is after the removing the phosphate group from at least one tyrosine residue.
